Skip to main content
. 2021 Dec 16;150(7):1101–1112. doi: 10.1002/ijc.33878

TABLE 4.

Univariable and multivariable associations of age with early mortality a due to AML (excl. APL and ML‐DS) in children and AYAs (0‐39 years), the Netherlands, 1990‐2015

Univariable Adjusted 1 b Adjusted 2 c
Variable Nearly death OR 95% CI P‐value OR 95% CI P‐value OR 95% CI P‐value
Age
Children (0‐17 years) 39 1.00 (ref) 1.00 (ref) 1.00 (ref)
AYAs (18‐39 years) 75 0.97 (0.65‐1.45) .89 0.95 (0.63‐1.42) .80 0.68 (0.44‐1.04) .07
Age (years)
0 13 6.47 (2.65‐15.79) <.001 7.23 (2.93‐17.86) <.001 6.74 (2.67‐17.00) <.001
1‐9 9 1.00 (ref) 1.00 (ref) 1.00 (ref)
10‐17 17 2.34 (1.02‐5.34) .04 2.40 (1.05‐5.51) .04 2.12 (0.91‐4.93) .08
18‐29 29 1.88 (0.88‐4.03) .10 1.86 (0.86‐3.99) .11 1.19 (0.54‐2.63) .66
30‐39 46 2.22 (1.07‐4.59) .03 2.26 (1.09‐4.70) .03 1.57 (0.74‐3.34) .24

Note: Statistically significant P values (P < .05) are displayed in bold.

Abbreviations: AML, acute myeloid leukemia; APL, acute promyelocytic leukemia; AYAs, adolescents and young adults; CI, confidence interval; ML‐DS, myeloid leukemia associated with Down syndrome; OR, odds ratio.

a

Early mortality was defined as death within 30 days of diagnosis.

b

Adjusted for sex (male, female) and period of diagnosis (1990‐1999, 2000‐2009, 2010‐2015).

c

Adjusted for sex (male, female), period of diagnosis (1990‐1999, 2000‐2009, 2010‐2015) and site of primary treatment (nonacademic hospital, academic hospital).